Tamoxifen for the prevention of breast cancer: Important questions remain unanswered, and existing trials should continue

por Bruzzi, Paolo
Publicado em 1998

Non-drug industry funded research

por Bruzzi, Paolo
Publicado em 2008

Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system

por Galeone, Carlotta, Bruzzi, Paolo, Jommi, Claudio
Publicado no BMJ Open (2021)

NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only mic...

por Tinterri, Corrado, Canavese, Giuseppe, Bruzzi, Paolo, Dozin, Beatrice
Publicado no Contemp Clin Trials Commun (2019)

Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study

por Pavanello, Sofia, Varesco, Liliana, Gismondi, Viviana, Bruzzi, Paolo, Bolognesi, Claudia
Publicado no PLoS One (2018)

Strategy for randomised clinical trials in rare cancers

por Tan, Say-Beng, Dear, Keith B G, Bruzzi, Paolo, Machin, David
Publicado em 2003

Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)

por Beccaro, Monica, Costantini, Massimo, Rossi, Paolo Giorgi, Miccinesi, Guido, Grimaldi, Maria, Bruzzi, Paolo
Publicado em 2006

Clinical Application of Micronucleus Test: A Case-Control Study on the Prediction of Breast Cancer Risk/Susceptibility

por Bolognesi, Claudia, Bruzzi, Paolo, Gismondi, Viviana, Volpi, Samantha, Viassolo, Valeria, Pedemonte, Simona, Varesco, Liliana
Publicado no PLoS One (2014)

Identification of a Prognostic Signature Based on the Expression of Genes Related to the Insulin Pathway in Early Breast Cancer

por Gennari, Alessandra, Sormani, Mariapia, Puntoni, Matteo, Martini, Veronica, Amaro, Adriana, Bruzzi, Paolo, Pfeffer, Ulrich
Publicado no Breast Care (Basel) (2021)

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)

por Di Maio, Massimo, Bruzzi, Paolo, Perrone, Francesco, Torri, Valter, Montemurro, Filippo, Tiseo, Marcello, Vasile, Enrico
Publicado no ESMO Open (2016)

Mortality among workers exposed to asbestos at the shipyard of Genoa, Italy: a 55 years follow-up

por Merlo, Domenico Franco, Bruzzone, Marco, Bruzzi, Paolo, Garrone, Elsa, Puntoni, Riccardo, Maiorana, Lucia, Ceppi, Marcello
Publicado no Environ Health (2018)

Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer

por Mustacchi, Giorgio, Sormani, Maria Pia, Bruzzi, Paolo, Gennari, Alessandra, Zanconati, Fabrizio, Bonifacio, Daniela, Monzoni, Adriana, Morandi, Luca
Publicado em 2013

The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations

por Ricci, Maria Teresa, Pennese, Loredana, Gismondi, Viviana, Perfumo, Chiara, Grasso, Marina, Gennaro, Elena, Bruzzi, Paolo, Varesco, Liliana
Publicado em 2014

Prevalence of Prostate Cancer at Different Clinical Stages in Italy: Estimated Burden of Disease Based on a Modelling Study

por Spandonaro, Federico, D’Angela, Daniela, Polistena, Barbara, Bruzzi, Paolo, Iacovelli, Roberto, Luccarini, Irene, Stagni, Paola, Brigido, Alessia
Publicado no Biology (Basel) (2021)

Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

por Del Bono, Valerio, Delfino, Emanuele, Furfaro, Elisa, Mikulska, Malgorzata, Nicco, Elena, Bruzzi, Paolo, Mularoni, Alessandra, Bassetti, Matteo, Viscoli, Claudio
Publicado em 2011

An extended assessment of bowel habits in a general population

por Bassotti, Gabrio, Bellini, Massimo, Pucciani, Filippo, Bocchini, Renato, Bove, Antonio, Alduini, Pietro, Battaglia, Edda, Bruzzi, Paolo, Group, Italian Constipation Study
Publicado no World J Gastroenterol (2004)

Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients

por Griseri, Paola, Garrone, Ornella, Lo Sardo, Alessandra, Monteverde, Martino, Rusmini, Marta, Tonissi, Federica, Merlano, Marco, Bruzzi, Paolo, Lo Nigro, Cristiana, Ceccherini, Isabella
Publicado no Oncotarget (2016)

The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018

por Ascierto, Paolo A., Bruzzi, Paolo, Eggermont, Alexander, Hamid, Omid, Tawbi, Hussein A., van Akkooi, Alexander, Testori, Alessandro, Caracò, Corrado, Puzanov, Igor, Perrone, Francesco
Publicado no J Transl Med (2019)

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

por Cabibbo, Giuseppe, Celsa, Ciro, Enea, Marco, Battaglia, Salvatore, Rizzo, Giacomo Emanuele Maria, Grimaudo, Stefania, Matranga, Domenica, Attanasio, Massimo, Bruzzi, Paolo, Craxì, Antonio, Cammà, Calogero
Publicado no Cancers (Basel) (2020)

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

por Aiello, Marco Maria, Solinas, Cinzia, Santoni, Matteo, Battelli, Nicola, Restuccia, Nunzio, Latteri, Fiorenza, Paratore, Sabrina, Verderame, Francesco, Albanese, Giuseppina Valeria, Bruzzi, Paolo, Soto Parra, Hector Josè
Publicado no Front Oncol (2020)